Simpler
solutions for
your OR

Join our webinar

Discover our solutions to combat Healthcare associated infections

Register

THE DIFFERENCE IS

PUTTING PRECISION
TO WORK

THE DIFFERENCE IS

PUTTING PRECISION
TO WORK

The first and only premixed, ready-to-use sterile PVP-I wound irrigation system

Thank you for inquiring about the new BD Surgiphor™ Sterile Wound Irrigation System. A solutions expert will be in touch soon.


Discovery. Diagnostics. Delivery.

Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.

Discovery. Diagnostics. Delivery.

Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.

Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.

Webinar Objectives:

  • Describe the current global impact of bloodborne disease
  • Describe occupational exposure incidents for needlesticks and sharps injuries
  • Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
  • Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
  • Illustrate an effective pathway for reporting exposure incidents and injuries
  • Define processes for post-exposure medical treatment and prophylaxis
  • Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world

Save Your Seat


Confidence in surgical performance through sterility


Sterility support

Terminally sterilized solution provides a 10-6 level of sterility assurance1

99.99% reduction

PVP-I is a preservative of the solution that protects against Candida albicans, Pseudomonas aeruginosa, Aspergillus brasiliensis, Escherichia coli and Staphylococcus aureus2,3


One in a million

Chance that a single viable microorganism will survive in the solution1

24-hour protection

Amount of time microbial growth is averted after the bottle of solution is opened1

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Video title here

Play

Fast microbial killer

In vitro antimicrobial efficacy of PVP-I as a preservative in the BD Surgiphor™ Solution was found to have a faster kill time for Methicillin-resistant Staphylococcus aureus at all-time points up to 5 minutes to that of Irrisept.3,4

Minimal cytotoxicity

In an in vitro study, the BD Surgiphor™ System exhibited minimal toxicity when compared to Irrisept and Bactisure at 24 hours.5,6

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Let's have a conversation

Hospitals and healthcare facilities

BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.

Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>

Placeholder

Pellentesque habitant morbi

  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada

Placeholder

Pellentesque habitant morbi

  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Store Tab

360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.

360° rotation knob is effectively sized

360° rotation knob is effectively sized

360° rotation knob is effectively sized

More product details


A first and only in surgical solutions

The BD Surgiphor™ Sterile Wound Irrigation System is the first and only premixed PVP-I wound irrigation solution. This well-known antiseptic serves as a preservative within the solution. It provides a broad-spectrum antimicrobial effect against gram-positive and gram-negative bacteria and yeast to reduce the risk of unwanted microbial growth in the solution after the bottle is opened.

Easy and ready to use
450 mL compressible plastic bottles

Concave bottle design
Prevents rolling and allows users to generate pressure of the solution through manual compression

Premixed terminally sterile solution
0.5% PVP-I formulation with 0.9% saline, phosphate iodine buffer and vitamin E TPGS

Sterile rinse
Terminally sterile 0.9% saline rinse

Hospitals and healthcare facilities

BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.

Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>

Hospitals and healthcare facilities

BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.

Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>

*Required field

Your personal data will be held and processed in accordance with our Data Protection Notice.

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Let's have a conversation

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ready to discover simpler solutions for your OR?

Let’s talk.

REFERENCES
1. Data on file. Data generated in a preclinical model. Data may not correlate to performance in humans. Please consult package insert for detailed safety information and instructions for use.
2. (ATCC #10231), (ATCC #9027), (ATCC #16404), (ATCC #8739), (ATCC #6538).
3. 2 PVP-I is a preservative in the solution and is not intended to be used as an antimicrobial.
4. (ATCC #33591) Product should be used only within 24 hours of opening per IFU.
5. 1-10% dilution in MTT and live/dead cell assay
6. Stephen F. Badylak, DVM, PhD, MD. In Vitro Evaluation of Irrigant Cytotoxicity to Mammalian Cells. McGowan Institute for Regenerative Medicine; 2021. Prelinical data may not correlate to use in humans. Dr. Badylak is a paid consultant of BD.

BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.

Contact us | Unsubscribe | My profile